151 related articles for article (PubMed ID: 6184994)
1. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Horton R
Am J Nephrol; 1982; 2(3):157-63. PubMed ID: 6184994
[No Abstract] [Full Text] [Related]
2. Benign prostatic hyperplasia: a disorder of androgen metabolism in the male.
Horton R
J Am Geriatr Soc; 1984 May; 32(5):380-5. PubMed ID: 6201524
[No Abstract] [Full Text] [Related]
3. Androgen metabolism in patients with benign prostatic hypertrophy.
Voigt KD; Horst HJ; Krieg M
Vitam Horm; 1975; 33():417-38. PubMed ID: 59462
[No Abstract] [Full Text] [Related]
4. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
Lloyd JW; Thomas JA; Mawhinney MG
Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
[TBL] [Abstract][Full Text] [Related]
5. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
6. [Is the prostatic adenoma of hormonal origin].
Bercovici JP; Morfin R; Charles JF
Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
[TBL] [Abstract][Full Text] [Related]
7. Quantification of androgen binding, androgen tissue levels, and sex hormone-binding globulin in prostate, muscle and plasma of patients with benign prostatic hypertrophy.
Krieg M; Bartsch W; Herzer S; Becker H; Voigt KD
Acta Endocrinol (Copenh); 1977 Sep; 86(1):200-15. PubMed ID: 71838
[No Abstract] [Full Text] [Related]
8. [Androgen and estrogen metabolism in human benign prostatic hyperplasia (BPH)].
Krieg M; Weisser H; Tunn S
Verh Dtsch Ges Pathol; 1993; 77():19-24. PubMed ID: 7511279
[TBL] [Abstract][Full Text] [Related]
9. Steroid hormones and the pathogenesis of benign prostatic hyperplasia.
Griffiths K; Eaton CL; Harper ME; Peeling B; Davies P
Eur Urol; 1991; 20 Suppl 1():68-77. PubMed ID: 1722166
[TBL] [Abstract][Full Text] [Related]
10. Testosterone and dihydrotestosterone levels in the transition zone correlate with prostate volume.
Pejčić T; Tosti T; Tešić Ž; Milković B; Dragičević D; Kozomara M; Čekerevac M; Džamić Z
Prostate; 2017 Jul; 77(10):1082-1092. PubMed ID: 28594074
[TBL] [Abstract][Full Text] [Related]
11. Androgen binding and metabolism in the human prostate.
Attramadal A; Tveter KJ; Weddington SC; Djöseland O; Naess O; Hansson V; Torgersen O
Vitam Horm; 1975; 33():247-64. PubMed ID: 59460
[No Abstract] [Full Text] [Related]
12. Evaluation of androgen metabolism studies in human prostate cancer--correlation with zinc levels.
Habib FK
Prev Med; 1980 Sep; 9(5):650-6. PubMed ID: 6159623
[No Abstract] [Full Text] [Related]
13. Recent studies on the mechanism of action of testosterone.
Wilson JD
N Engl J Med; 1972 Dec; 287(25):1284-91. PubMed ID: 4119318
[No Abstract] [Full Text] [Related]
14. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
15. Dihydrotestosterone in prostatic hypertrophy. I. The formation and content of dihydrotestosterone in the hypertrophic prostate of man.
Siiteri PK; Wilson JD
J Clin Invest; 1970 Sep; 49(9):1737-45. PubMed ID: 4194768
[TBL] [Abstract][Full Text] [Related]
16. Prostatic growth: new insights into hormonal regulation.
McConnell JD
Br J Urol; 1995 Jul; 76 Suppl 1():5-10. PubMed ID: 7544215
[No Abstract] [Full Text] [Related]
17. Clinical and experimental studies of benign prostatic hyperplasia.
Coffey DS; Walsh PC
Urol Clin North Am; 1990 Aug; 17(3):461-75. PubMed ID: 1695775
[TBL] [Abstract][Full Text] [Related]
18. Androgen metabolism in the hypertrophic prostate.
Wilson JD; Gloyna RE; Siiteri PK
J Steroid Biochem; 1975; 6(3-4):443-5. PubMed ID: 52762
[No Abstract] [Full Text] [Related]
19. Intraprostatic testosterone and dihydrotestosterone. Part I: concentrations and methods of determination in men with benign prostatic hyperplasia and prostate cancer.
van der Sluis TM; Vis AN; van Moorselaar RJ; Bui HN; Blankenstein MA; Meuleman EJ; Heijboer AC
BJU Int; 2012 Jan; 109(2):176-82. PubMed ID: 21992222
[TBL] [Abstract][Full Text] [Related]
20. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
